- Home
- SIG vs ARWR Comparison
SIG vs ARWR Comparison
Compare SIG & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIG
- ARWR
- Stock Information
- Founded
- SIG 1950
- ARWR 2003
- Country
- SIG Bermuda
- ARWR United States
- Employees
- SIG N/A
- ARWR N/A
- Industry
- SIG Consumer Specialties
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- SIG Consumer Discretionary
- ARWR Health Care
- Exchange
- SIG Nasdaq
- ARWR Nasdaq
- Market Cap
- SIG 2.2B
- ARWR 1.8B
- IPO Year
- SIG N/A
- ARWR 1993
- Fundamental
- Price
- SIG $64.40
- ARWR $13.03
- Analyst Decision
- SIG Buy
- ARWR Buy
- Analyst Count
- SIG 4
- ARWR 11
- Target Price
- SIG $69.00
- ARWR $41.44
- AVG Volume (30 Days)
- SIG 935.2K
- ARWR 1.6M
- Earning Date
- SIG 06-03-2025
- ARWR 05-12-2025
- Dividend Yield
- SIG 1.99%
- ARWR N/A
- EPS Growth
- SIG N/A
- ARWR N/A
- EPS
- SIG N/A
- ARWR N/A
- Revenue
- SIG $6,703,800,000.00
- ARWR $2,500,000.00
- Revenue This Year
- SIG $0.64
- ARWR $4,380.43
- Revenue Next Year
- SIG $1.26
- ARWR $64.24
- P/E Ratio
- SIG N/A
- ARWR N/A
- Revenue Growth
- SIG N/A
- ARWR N/A
- 52 Week Low
- SIG $45.55
- ARWR $9.57
- 52 Week High
- SIG $112.06
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- SIG 65.50
- ARWR 47.38
- Support Level
- SIG $59.90
- ARWR $12.44
- Resistance Level
- SIG $65.62
- ARWR $14.97
- Average True Range (ATR)
- SIG 2.25
- ARWR 0.74
- MACD
- SIG 0.59
- ARWR 0.11
- Stochastic Oscillator
- SIG 90.15
- ARWR 37.01
About SIG Signet Jewelers Limited
Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.